Furthermore, MDS with biallelic TP53 inactivation (MDS-biTP53) has been defined; it is identified by two or more TP53 mutations, or one mutation with evidence of TP53 copy number loss or loss of heterozygosity. The gene discussed is TP53; the disease is myelodysplastic syndrome.